We report a patient in whom permanent endocardial pacing was accomplished by passage of the electrode through a mechanical tricuspid valve. Echocardiography study showed a minimal tricuspid regurgitation.
The online version of this article (doi:10.1186/1749-8090-3-42) contains supplementary material, which is available to authorized users.
Authors' contributions
JS and JR were the surgeons. All authors read and approved the final manuscript.
Case report
A 66 year-old woman was admitted to our hospital, because she had an episode of cardiovascular collapse requiring cardiopulmonary resucitation four days after cardiac operation in other hospital. The patient had previously undergone one closed and three open heart procedures. The first operation was a closed mitral surgery by a left thoracotomy. After nine years she needed new surgery because she had mitral stenosis and a mitral comisurotomy was done throught a sternotomy and under cardiopulmonary bypass. Ten years after the second operation, because she had mitral stenosis with extensive calcification of the anterior leaflet and aortic and tricuspid regurgitation, a double mitro-aortic valve replacement was done with two Bjork- Shiley (Shiley Inc – Irvine. CA, USA) prostheses. Also a De Vega tricuspid annuloplasty was performed. In 2002 symptoms of congestive heart failure, dyspnea and severe tricuspid insufficiency necessitated replacement of the tricuspid valve by a CarboMedics Prosthesis (CarboMedics Inc, Austin, Tex – USA). This operation was performed through right thoracotomy. The patient was discharged from the hospital one week later.
Four days later, she was admitted to our hospital because she had an episode of cardiovascular collapse requiring cardiopulmonary resucitation. The physical examination was remarkable for elevated jugular venous pressure.
Anzeige
Chest radiography revealed the presence of important bilateral pleural effusion and a right ventricle enlargement. The ECG showed atrial fibrillation with a ventricular rate of 35 beats/min. No Digoxin or Beta Blocker treatment was present.
Transthoracic echocardiography demostrated a normal function of the three prosthesis and a decreased right ventricular function.
The patient who was on an anticoagulant therapy with coumadin, was put on a regimen of heparin. After three days and to avoid a new thoracotomy(Fifth) a left ventricular pacing with an endocardial lead through the coronary sinus was performed. The stimulation threshold there was 4 V at 0,5 ms and the R wave amplitude was 10 mV. New positions were tried and due to the high stimulation threshold, we decided to place the lead in the right ventricle through the tricuspid prosthesis (fig 1). The stimulation Threshold was 0,6 V at 0,5 ms. The R wave amplitude was 16 mV, the impedance was 700 om. The electrocardiogram showed normal ventricular pacing, the lead was connected to a single chamber rate adaptative pacemaker (Kairos SR. Biotronik) which was placed in a subfascial prepectoral pocket. After a week an x-ray revealed that the lead position remained stable.
Transesophageal echocardiography showed a mild tricuspid regurgitation with a pulmonary artery pressure of 60 mmHg and a right ventricle with a better function than before the implantation.
Figure 1
Two different projections with the lead through the tricuspid prosthesis. Only one leaflet is affected.
×
Anzeige
Discussion
In this article we reported the first case, to our knowledge, of a transvenous right ventricular pacing in a patient with tricuspid mechanical prosthesis and multiple previous heart surgeries. Patients undergoing tricuspid valve replacement frequently require permanent pacing and if a permanent pacemaker was not implanted at the time of valve replacement, a new thoracotomy would be necessary for epicardial lead implantation. A transvenous lead implantation with Ventricular pacing from the coronary sinus is a feasible approach in patients with tricuspid mechanical prosthesis [1], but as was described by Lee [2] acute stimulation thresholds are higher and this was the case with our patient.
The endoscopic surgery is another possibility, but patients with obvious dense adhesions not be scheduled for an endoscopic procedure [3] because a failure during surgery requires obligatory conversion to an open procedure and may be exceptionally dangerous in patients with multiple previous cardiothoracic surgeries.
Pernenkil [4] described a permanent endocardial pacing through a porcine bioprosthetic tricuspid valve without problems in a long term follow-up, but as was described by Winter [1], transvenous right ventricular endocardial pacing is contraindicated in patients with tricuspid mechanical prosthesis and this was true with the use of old generation prostheses (monodisc).
With bileaflet prosthesis it is possible to pace the right ventricle without important hemodynamics alterations. Since only one leaflet is affected, as in our case, the tricuspid regurgitation is minimal.
Consent
Written informed consent was obtained from the patient for publication of this case Report and accompanying images.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors' contributions
JS and JR were the surgeons. All authors read and approved the final manuscript.
Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.
Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.
Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.
Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.